CARIS LIFE SCIENCES INC (CAI)

Sector: Health Care

Name	Position	Age	Qualifications and Experience	Committee Memberships	Filing Year
Brian J. Brille	Vice Chairman and Executive Vice President of Caris Life Sciences	65	["served as a member of the board of trustees at the Cancer Research Institute","served as a member of the board of directors at the International Biomedical Research Alliance","various finance-related roles for Bank of America Merrill Lynch","Chairman & President of Asia Pacific from 2009 to 2013","Head of Corporate and Investment Banking from 2005 to 2008","Head of Healthcare Investment Banking from 1999 to 2004","founded Morgan Stanley’s Healthcare Services Investment Banking Group","holds a Juris Doctor from Stanford Law School","holds a Master in Public Policy from the Harvard Kennedy School","holds a Bachelor of Science in Accounting from the University of Illinois"]	[]	2026
Danny Phillips	Former Chief Financial Officer and Senior EVP of AdvancePCS; Director	66	["Owner of Diamond P Longhorn Ranch","Manages own financial investments","Chairperson of Fortress Youth Development Center from 2007 to 2015","Served on board of directors of Mission Increase Fort Worth","Former board member of Texas Mutual Insurance Company for thirteen years","Served on board of regents at Pepperdine University","Investment board of Abilene Christian University","Chief Financial Officer and Senior Executive Vice President at AdvancePCS for over 11 years","Various senior financial roles at Harken Energy Corporation","Senior financial roles at Aloha Petroleum, Ltd.","Bachelor of Arts in Accounting from Abilene Christian University"]	["Chair","Audit"]	2026
David Dean Halbert	Founder, Chairman and CEO of Caris Life Sciences	70	[]	[]	2026
David Dean Halbert, D. Sc. (h.c.)	Nominated for Election to a Term Expiring at the 2027 Annual Meeting; Founder, Chairman and Chief Executive Officer	70	["Founder of the Company","Chairman and Chief Executive Officer since inception","Former Chairman and CEO of Caris Diagnostics","Former Chairman and CEO of AdvancePCS Inc.","Bachelor of Business Administration from Abilene Christian University","Honorary Doctor of Science from Abilene Christian University"]	[]	2026
David Fredrickson	EVP, Oncology Business Unit of AstraZeneca PLC; Executive Vice-President, Oncology Business Unit	51	["Extensive experience in the pharmaceutical and oncology industries","Leadership roles as a director and executive officer","Bachelor of Arts in Government from Georgetown University"]	[]	2026
Jeffrey Vacirca, M.D., F.A.C.P.	Chief Executive Officer and Chairman of the Board of New York Cancer & Blood Specialists; Co-Founder of OneOncology; Director	57	["Chief Executive Officer and Chairman of the Board of New York Cancer & Blood Specialists","President and Co-Founder of National Translational Research Group","Medical Director and Strategic Advisor for the International Oncology Network at Amerisource Bergen","Medical Director of the Oncology Network Development at Mount Sinai Health Network","Associate clinical professor at Icahn School of Medicine at Mount Sinai, New York","Past president of the Community Oncology Alliance","Co-founder of OneOncology","Founder and Chairman of the Board of Directors of the New York Cancer Foundation","Experience serving on the boards of several companies"]	["Executive Committee","Scientific Advisory Board"]	2026
Jon S. Halbert	Co-Founder and Former Vice Chairman, AdvancePCS; Director	66	["Extensive experience in the healthcare and technology industries","Years of experience in leadership roles as a director and executive officer","Bachelor of Accounting from Abilene Christian University"]	[]	2026
Joseph E. Gilliam	President and Chief Operating Officer of Glaukos Corporation	50	["Chief Financial Officer and Senior Vice President, Corporate Development at Glaukos Corporation","Managing Director in the Healthcare Investment Banking group at JPMorgan Chase & Co.","Experience in mergers and acquisitions, public equity offerings, bank lending, bond offerings","Auditor at PricewaterhouseCoopers LLP","Bachelor of Science in accounting from the Kelly School of Business at Indiana University"]	["Member","Audit","Compensation"]	2026
Laura I. Johansen	Former President of Caris Life Sciences; Former SVP and General Counsel of AdvancePCS; Director	60	["Founded and serves as the President of Pence Management","Former President of Halbert & Associates","Former General Counsel of AdvancePCS","Former Senior Vice President and Corporate Secretary of AdvancePCS","Former Associate in the Corporate and Securities Group of Akin, Gump, Strauss, Hauer and Feld LLP","Bachelor of Business Administration in Marketing","Juris Doctor from the University of Texas","Extensive experience in the healthcare industry"]	["Member","Compensation"]	2026
Lloyd B. Minor, M.D.	Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine; Director	68	["Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine","Vice President for Medical Affairs at Stanford University","Professor of Otolaryngology—Head and Neck Surgery","Professor of Neurobiology and Bioengineering","Provost and Senior Vice President for Academic Affairs at Johns Hopkins University","Department’s Andelot Professor and Director (Chair) at Johns Hopkins University","Member of the board of directors of Biogen","Advisor to several private healthcare companies and healthcare-focused investors"]	[]	2026
Peter M. Castleman	Lead Independent Director, Caris Life Sciences Former Chairman and Managing Partner, J.H. Whitney & Co.	69	["private company investor","entrepreneur","Chairman and Managing Partner of J. H. Whitney & Co., LLC","oversaw private equity firm's activities","worked in Morgan Stanley's leveraged buyout investment group","international banking officer at J.P. Morgan","Master of Business Administration from Harvard Business School","Bachelor of Arts from Duke University"]	["Audit","Compensation"]	2026

Name

Position

Age

Qualifications and Experience

Committee Memberships

Filing Year

Brian J. Brille

Vice Chairman and Executive Vice President of Caris Life Sciences

["served as a member of the board of trustees at the Cancer Research Institute","served as a member of the board of directors at the International Biomedical Research Alliance","various finance-related roles for Bank of America Merrill Lynch","Chairman & President of Asia Pacific from 2009 to 2013","Head of Corporate and Investment Banking from 2005 to 2008","Head of Healthcare Investment Banking from 1999 to 2004","founded Morgan Stanley’s Healthcare Services Investment Banking Group","holds a Juris Doctor from Stanford Law School","holds a Master in Public Policy from the Harvard Kennedy School","holds a Bachelor of Science in Accounting from the University of Illinois"]

[]

2026

Danny Phillips

Former Chief Financial Officer and Senior EVP of AdvancePCS; Director

["Owner of Diamond P Longhorn Ranch","Manages own financial investments","Chairperson of Fortress Youth Development Center from 2007 to 2015","Served on board of directors of Mission Increase Fort Worth","Former board member of Texas Mutual Insurance Company for thirteen years","Served on board of regents at Pepperdine University","Investment board of Abilene Christian University","Chief Financial Officer and Senior Executive Vice President at AdvancePCS for over 11 years","Various senior financial roles at Harken Energy Corporation","Senior financial roles at Aloha Petroleum, Ltd.","Bachelor of Arts in Accounting from Abilene Christian University"]

["Chair","Audit"]

2026

David Dean Halbert

Founder, Chairman and CEO of Caris Life Sciences

[]

2026

David Dean Halbert, D. Sc. (h.c.)

Nominated for Election to a Term Expiring at the 2027 Annual Meeting; Founder, Chairman and Chief Executive Officer

["Founder of the Company","Chairman and Chief Executive Officer since inception","Former Chairman and CEO of Caris Diagnostics","Former Chairman and CEO of AdvancePCS Inc.","Bachelor of Business Administration from Abilene Christian University","Honorary Doctor of Science from Abilene Christian University"]

[]

2026

David Fredrickson

EVP, Oncology Business Unit of AstraZeneca PLC; Executive Vice-President, Oncology Business Unit

["Extensive experience in the pharmaceutical and oncology industries","Leadership roles as a director and executive officer","Bachelor of Arts in Government from Georgetown University"]

[]

2026

Jeffrey Vacirca, M.D., F.A.C.P.

Chief Executive Officer and Chairman of the Board of New York Cancer & Blood Specialists; Co-Founder of OneOncology; Director

["Chief Executive Officer and Chairman of the Board of New York Cancer & Blood Specialists","President and Co-Founder of National Translational Research Group","Medical Director and Strategic Advisor for the International Oncology Network at Amerisource Bergen","Medical Director of the Oncology Network Development at Mount Sinai Health Network","Associate clinical professor at Icahn School of Medicine at Mount Sinai, New York","Past president of the Community Oncology Alliance","Co-founder of OneOncology","Founder and Chairman of the Board of Directors of the New York Cancer Foundation","Experience serving on the boards of several companies"]

["Executive Committee","Scientific Advisory Board"]

2026

Jon S. Halbert

Co-Founder and Former Vice Chairman, AdvancePCS; Director

["Extensive experience in the healthcare and technology industries","Years of experience in leadership roles as a director and executive officer","Bachelor of Accounting from Abilene Christian University"]

[]

2026

Joseph E. Gilliam

President and Chief Operating Officer of Glaukos Corporation

["Chief Financial Officer and Senior Vice President, Corporate Development at Glaukos Corporation","Managing Director in the Healthcare Investment Banking group at JPMorgan Chase & Co.","Experience in mergers and acquisitions, public equity offerings, bank lending, bond offerings","Auditor at PricewaterhouseCoopers LLP","Bachelor of Science in accounting from the Kelly School of Business at Indiana University"]

["Member","Audit","Compensation"]

2026

Laura I. Johansen

Former President of Caris Life Sciences; Former SVP and General Counsel of AdvancePCS; Director

["Founded and serves as the President of Pence Management","Former President of Halbert & Associates","Former General Counsel of AdvancePCS","Former Senior Vice President and Corporate Secretary of AdvancePCS","Former Associate in the Corporate and Securities Group of Akin, Gump, Strauss, Hauer and Feld LLP","Bachelor of Business Administration in Marketing","Juris Doctor from the University of Texas","Extensive experience in the healthcare industry"]

["Member","Compensation"]

2026

Lloyd B. Minor, M.D.

Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine; Director

["Carl and Elizabeth Naumann Dean of the Stanford University School of Medicine","Vice President for Medical Affairs at Stanford University","Professor of Otolaryngology—Head and Neck Surgery","Professor of Neurobiology and Bioengineering","Provost and Senior Vice President for Academic Affairs at Johns Hopkins University","Department’s Andelot Professor and Director (Chair) at Johns Hopkins University","Member of the board of directors of Biogen","Advisor to several private healthcare companies and healthcare-focused investors"]

[]

2026

Peter M. Castleman

Lead Independent Director, Caris Life Sciences Former Chairman and Managing Partner, J.H. Whitney & Co.

["private company investor","entrepreneur","Chairman and Managing Partner of J. H. Whitney & Co., LLC","oversaw private equity firm's activities","worked in Morgan Stanley's leveraged buyout investment group","international banking officer at J.P. Morgan","Master of Business Administration from Harvard Business School","Bachelor of Arts from Duke University"]

["Audit","Compensation"]

2026